Cargando…
PATIENTS WITH MODERATE COVID-19: COMPARISON OF PROCALCITONIN SERUM LEVEL IN TWO GROUPS WITH DIFFERENT CHEST IMAGING FINDINGS
Autores principales: | SHAFIEPOUR, M., ABDOLLAHI, S., ALINAGHI LANGARI, A., DABIRI, S., YOUSEFI, M., NAKHAEI, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212290/ http://dx.doi.org/10.1016/j.chest.2021.12.184 |
Ejemplares similares
-
PROCALCITONIN AS A PREDICTOR OF CLINICAL OUTCOMES IN PATIENTS WITH COVID-19
por: JACKSON, IAN, et al.
Publicado: (2021) -
ROLE OF PROCALCITONIN IN PATIENTS WITH COVID-19 AND HOSPITAL-ACQUIRED PNEUMONIA
por: KUMAR, MYTHRI ANIL, et al.
Publicado: (2022) -
CT CHEST FINDINGS IN SEVERE MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS INFECTION
por: ALKINDI, F., et al.
Publicado: (2022) -
COST ANALYSIS FOR USE OF PROCALCITONIN AND INFLAMMATORY MARKERS IN COVID-19 VENTILATOR-ASSOCIATED PNEUMONIA
por: KIM, A., et al.
Publicado: (2022) -
MANAGEMENT AND OCCURRENCE OF CHEST EMPYEMA IN COVID-19 ERA
por: STAMATELOPOULOS, A., et al.
Publicado: (2022)